Profil
Zohar Milman is currently Chief Operating Officer at Tarsier Pharma Ltd. since 2017.
Formerly, Mr. Milman was Manager-Business Development at Van Leer Xenia Ventures from 2014 to 2016.
Education includes graduate studies at The Hebrew University of Jerusalem.
Postes actifs de Zohar Milman
| Sociétés | Poste | Début |
|---|---|---|
| TARSIER PHARMA LTD. | Directeur des opérations | 01/03/2017 |
Anciens postes connus de Zohar Milman
| Sociétés | Poste | Fin |
|---|---|---|
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures in companies located in Israel. The firm targets companies operating in the fields of data driven biotechnology and digital pharma. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.7- 1 million. It also makes follow on investments. | Corporate Officer/Principal | 01/01/2016 |
Formation de Zohar Milman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Van Leer Xenia Ventures
Van Leer Xenia Ventures Investment ManagersFinance Van Leer Xenia Ventures in companies located in Israel. The firm targets companies operating in the fields of data driven biotechnology and digital pharma. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.7- 1 million. It also makes follow on investments. | Finance |
Tarsier Pharma Ltd.
Tarsier Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Health Technology |
















